CN113577155A - Medicine for treating burn and its preparation method - Google Patents
Medicine for treating burn and its preparation method Download PDFInfo
- Publication number
- CN113577155A CN113577155A CN202111020605.3A CN202111020605A CN113577155A CN 113577155 A CN113577155 A CN 113577155A CN 202111020605 A CN202111020605 A CN 202111020605A CN 113577155 A CN113577155 A CN 113577155A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- catechu
- burn
- cortex dictamni
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/241—Lead; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The application provides a medicine for treating burns and a preparation method thereof, and the medicine comprises 37-43 parts of rheum officinale, 36-43 parts of coptis chinensis, 18-22 parts of cortex dictamni, 150-168 parts of gypsum, 2-6 parts of keel, 17-24 parts of talc, 6-9 parts of cinnabar, 2-6 parts of catechu, 6-10 parts of yellow lead and 3-8 parts of borneol. Weighing the medicines according to a certain proportion, grinding and screening to obtain fine powder, coating the fine powder on the burnt part of a patient when in use, and wrapping with vaseline oil gauze. The medicine prepared by the application has high cure rate, and after scientific material selection and proportioning, the medicine composition has the effects of clearing heat and detoxicating, inhibiting bacteria and sterilizing, relieving swelling and pain, removing slough and promoting granulation, so that the wound surface is protected quickly after the medicine is taken, local sterility is formed to control infection, meanwhile, the slough and promoting granulation effects of the medicine prepared by the application promote the wound to heal quickly, the wound surface is sealed and protected in time, and the wound surface is naturally promoted to heal without external interference, so that no scar or pigmentation exists after healing.
Description
Technical Field
The application relates to the technical field of medicines, in particular to a medicine for treating burn and a preparation method thereof.
Background
Burn generally refers to tissue damage caused by heat (including hot liquid, steam, hot gas, flame, electric energy, chemical substances, radioactive rays, glowing metal liquid or solid, etc.), mainly refers to damage of skin or mucous membrane, and serious people can also damage other tissues. The main clinical symptoms after skin burn are: redness, swelling, pain, burning sensation, localized redness and swelling, weeping, blisters, and severe pain of the skin. If the burn is not treated in time, infection can be further caused, so that the burn needs to be treated in time, but most of the existing medicines for treating the burn have complex components, complex preparation, high cost, slow effect and long pain time of patients.
Disclosure of Invention
Aiming at the defects of the prior art, the application aims to provide the medicine for treating the burn and the preparation method thereof, the medicine is prepared by processing raw materials of rhubarb, coptis, cortex dictamni, gypsum, keel, talc, cinnabar, catechu, yellow lead, borneol and the like, and can quickly treat the burn and relieve the pain of a patient.
The technical scheme adopted by the application is as follows:
the medicine for treating the burn comprises the following raw medicines in parts by weight: 37-43 parts of rheum officinale, 36-43 parts of coptis chinensis, 18-22 parts of cortex dictamni, 150-168 parts of gypsum, 2-6 parts of keel, 17-24 parts of talc, 6-9 parts of cinnabar, 2-6 parts of catechu, 6-10 parts of yellow lead and 3-8 parts of borneol.
Further, the medicine for treating the burn comprises the following raw medicines in parts by weight: 40 parts of rheum officinale, 40 parts of coptis chinensis, 20 parts of cortex dictamni, 160 parts of gypsum, 4 parts of keel, 20 parts of talc, 8 parts of cinnabar, 4 parts of catechu, 8 parts of yellow lead and 5 parts of borneol.
Further, the medicine for treating the burn comprises the following raw medicines in parts by weight: 41 parts of rhubarb, 39 parts of coptis chinensis, 20 parts of cortex dictamni, 155 parts of gypsum, 5 parts of keel, 21 parts of talcum, 7 parts of cinnabar, 4 parts of catechu, 9 parts of yellow lead and 5 parts of borneol.
Further, the preparation method of the medicine for treating the burn comprises the following steps:
(1) washing radix et rhizoma Rhei, Coptidis rhizoma, cortex Dictamni Radicis, Catechu, and Plumbum Preparatium, and air drying;
(2) weighing rhubarb, coptis chinensis, cortex dictamni, gypsum, keel, talc, cinnabar, catechu, yellow lead and borneol according to a proportion, and putting the mixture into a traditional Chinese medicine ultrafine grinder to grind for 12-18 min;
(3) the ground coarse powder was sieved with a 120-mesh sieve to obtain a fine powder.
Further, a method for using the medicine for treating burn comprises the steps of coating fine powder on the burn part of a patient and wrapping the burn part with a vaseline oil gauze.
The beneficial effect of this application lies in:
the traditional Chinese medicine adopted by the application is scientifically prepared and proportioned, wherein: catechu has certain inhibition on staphylococcus aureus, pseudomonas aeruginosa, diphtheria bacillus, proteus bacillus, dysentery bacillus and typhoid bacillus for later use, and has obvious inhibition on tubercle bacillus for later use; plumbum Preparatium and Cinnabaris have effects of clearing heart heat, removing toxic substance and preventing corrosion, and can be used for treating skin ulcer, furuncle and pyogenic infections, and inhibiting and killing bacteria; gypsum Fibrosum, Os Draconis, and pulvis Talci have good therapeutic effects in clearing away heat and toxic materials, treating burn, stopping bleeding, and resisting allergy; the rhubarb, the cortex dictamni and the coptis have the effects of cooling blood and removing stasis, can reduce wound bleeding and promote blood stasis dissipation; the borneol has the effects of clearing heat and relieving swelling, can relieve symptoms of swelling and pain of wounds, and is beneficial to promoting wound healing.
The medicine for treating burns, which is obtained by processing the materials according to the proportion, can be used for treating the burn wound appropriately, the wound is protected quickly after the medicine is used, local sterility is formed to control infection, meanwhile, the damaged capillary vessel is closed quickly due to the scab film formed by fibrin exuded by an organism and tannin rich in the plant medicine in the application, and the exudation and the loss of tissue fluid are prevented; meanwhile, the medicine prepared by the application has the effects of removing the necrotic tissue and promoting tissue regeneration, promotes the wound to heal quickly, seals and protects the wound surface in time, and naturally promotes the tissue regeneration and heals without external interference, so that no scar or pigmentation exists after healing.
Detailed Description
The technical solutions in the embodiments of the present application will be clearly and completely described below with reference to the embodiments of the present application, and it is obvious that the described embodiments are only a part of the embodiments of the present application, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
Example 1
A medicine for treating burn is prepared from the following raw materials in parts by weight: 40 parts of rheum officinale, 40 parts of coptis chinensis, 20 parts of cortex dictamni, 160 parts of gypsum, 4 parts of keel, 20 parts of talc, 8 parts of cinnabar, 4 parts of catechu, 8 parts of yellow lead and 5 parts of borneol. The preparation method comprises the following steps:
(1) washing radix et rhizoma Rhei, Coptidis rhizoma, cortex Dictamni Radicis, Catechu, and Plumbum Preparatium, and air drying;
(2) weighing 200g of rheum officinale, 200g of coptis chinensis, 100g of cortex dictamni, 800g of gypsum, 20g of keel, 100g of talc, 40g of cinnabar, 20g of catechu, 40g of yellow lead and 25g of borneol, and putting the mixture into a traditional Chinese medicine superfine pulverizer to grind for 15 min;
(3) the ground coarse powder was sieved with a 120-mesh sieve to obtain a fine powder.
Example 2
A medicine for treating burn is prepared from the following raw materials in parts by weight: 41 parts of rhubarb, 39 parts of coptis chinensis, 20 parts of cortex dictamni, 155 parts of gypsum, 5 parts of keel, 21 parts of talcum, 7 parts of cinnabar, 4 parts of catechu, 9 parts of yellow lead and 5 parts of borneol. The preparation method comprises the following steps:
(1) washing radix et rhizoma Rhei, Coptidis rhizoma, cortex Dictamni Radicis, Catechu, and Plumbum Preparatium, and air drying;
(2) weighing 205g of rheum officinale, 195g of coptis chinensis, 100g of cortex dictamni, 775g of gypsum, 25g of keel, 105g of talc, 35g of cinnabar, 20g of catechu, 45g of yellow lead and 25g of borneol, and putting the mixture into a traditional Chinese medicine superfine pulverizer to grind for 15 min;
(3) the ground coarse powder was sieved with a 120-mesh sieve to obtain a fine powder.
Application example
1. Irritation test:
(1) when the medicine prepared by the application is used for contacting the skin of a mouse by a single administration for 6 hours, the medicine has no irritation to the damaged skin of the complete skin of the mouse.
(2) The medicine prepared by the application is continuously applied to the skin of a mouse for 7 days, and no irritation is generated to the intact skin and the damaged skin of the mouse when the medicine is observed for 7 days.
2. Therapeutic effects
(1) Case selection
A total of 240 patients were clinically selected, 67 patients were hospitalized, and 173 patients were outpatient. 93 cases of mild burn, 74 cases of moderate burn, 48 cases of severe burn and 25 cases of very severe burn. The two groups were evenly divided and treated with the drugs prepared in examples 1 and 2 of this application.
(2) Burn diagnostic criteria: the diagnosis standard of burn is the classification standard of the degree of light, medium, heavy and extra heavy burn, and the burn is classified into four types: (1) the first and second degree burns with the total area less than 10 percent are mild burns; (2) moderate burn is caused by the I and II degree burn or the III degree burn with the total area of 11-30 percent and the area of less than 10 percent; (3) the first and second degree burns with the total area between 30 percent and 50 percent or the severe burns with the area between 10 percent and 20 percent of the third degree burns; (4) the first and second degree burn with the total area of more than 51% or the third degree burn with the area of more than 21% is the extra-heavy degree burn.
(3) Method of treatment
The application is a pure traditional Chinese medicine ointment for external application, after conventional debridement and disinfection, different amounts of medicinal powder are applied to the burn part of a patient according to different burn degrees and burn areas, the burn part is bound by a vaseline oil yarn strip, 1 time every day, 3 days are a treatment course, the patient is generally cured in 2-5 treatment courses, and the treatment course can be properly increased for severe burn patients.
(4) Standard of care
The wound surface recovers natural skin color and natural physiological function, joint parts do not contracture or deform, and skin does not leave sequelae such as keloid, pruritus and the like, so that patients can recover normal life, study and work again.
(5) The treatment effect is as follows: clinical verification of years shows that the medicine provided by the embodiment has obvious curative effect by treating 240 patients. Specific treatment data are shown in table 1:
TABLE 1 statistical treatment results
As can be seen from the table 1, the cure rate of 240 cases of burn patients reaches 91.5 percent on average, the effect is obvious, and no adverse reaction and toxic or side effect are found, which indicates that the medicine has obvious curative effect on the aspect of treating the burn patients and has good popularization value. The cure cases of the group of the particularly severe burns in the example 2 are low because the number of cases is small, and the number of patients who are not cured in a single case has a large influence on the statistical results.
The medicine prepared by the application has high cure rate, and after scientific material selection and proportioning, the medicine composition has the effects of clearing heat and detoxicating, inhibiting bacteria and sterilizing, relieving swelling and pain, removing slough and promoting granulation, so that the wound surface is protected quickly after the medicine is taken, local sterility is formed to control infection, meanwhile, the slough and promoting granulation effects of the medicine prepared by the application promote the wound to heal quickly, the wound surface is sealed and protected in time, and the wound surface is naturally promoted to heal without external interference, so that no scar or pigmentation exists after healing.
The above description is only for the purpose of illustrating the preferred embodiments of the present application and is not to be construed as limiting the present application, and all equivalent variations and modifications within the scope of the present application are intended to be covered by the present application. Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.
Claims (5)
1. A medicine for treating burn is characterized in that: comprises the following raw medicines in parts by weight: 37-43 parts of rheum officinale, 36-43 parts of coptis chinensis, 18-22 parts of cortex dictamni, 150-168 parts of gypsum, 2-6 parts of keel, 17-24 parts of talc, 6-9 parts of cinnabar, 2-6 parts of catechu, 6-10 parts of yellow lead and 3-8 parts of borneol.
2. A medicament for the treatment of burns as claimed in claim 1, wherein: comprises the following raw medicines in parts by weight: 40 parts of rheum officinale, 40 parts of coptis chinensis, 20 parts of cortex dictamni, 160 parts of gypsum, 4 parts of keel, 20 parts of talc, 8 parts of cinnabar, 4 parts of catechu, 8 parts of yellow lead and 5 parts of borneol.
3. A medicament for the treatment of burns as claimed in claim 1, wherein: comprises the following raw medicines in parts by weight: 41 parts of rhubarb, 39 parts of coptis chinensis, 20 parts of cortex dictamni, 155 parts of gypsum, 5 parts of keel, 21 parts of talcum, 7 parts of cinnabar, 4 parts of catechu, 9 parts of yellow lead and 5 parts of borneol.
4. A process for the preparation of a medicament for the treatment of burns as claimed in claim 1, wherein: the method comprises the following steps:
(1) washing radix et rhizoma Rhei, Coptidis rhizoma, cortex Dictamni Radicis, Catechu, and Plumbum Preparatium, and air drying;
(2) weighing rhubarb, coptis chinensis, cortex dictamni, gypsum, keel, talc, cinnabar, catechu, yellow lead and borneol according to a proportion, and putting the mixture into a traditional Chinese medicine ultrafine grinder to grind for 12-18 min;
(3) the ground coarse powder was sieved with a 120-mesh sieve to obtain a fine powder.
5. The method of using a medicament for the treatment of burns as claimed in claim 1, wherein: when in use, the fine powder is applied to the burn part of a patient and wrapped by a vaseline oil gauze.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111020605.3A CN113577155A (en) | 2021-09-01 | 2021-09-01 | Medicine for treating burn and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111020605.3A CN113577155A (en) | 2021-09-01 | 2021-09-01 | Medicine for treating burn and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113577155A true CN113577155A (en) | 2021-11-02 |
Family
ID=78240560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111020605.3A Pending CN113577155A (en) | 2021-09-01 | 2021-09-01 | Medicine for treating burn and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113577155A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590133A (en) * | 2008-05-31 | 2009-12-02 | 武汉诚达日化研究所 | The manufacture method of treatment burn, scald powder |
-
2021
- 2021-09-01 CN CN202111020605.3A patent/CN113577155A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590133A (en) * | 2008-05-31 | 2009-12-02 | 武汉诚达日化研究所 | The manufacture method of treatment burn, scald powder |
Non-Patent Citations (2)
Title |
---|
孙世发主编: "《中华医方•外科篇(上)》", 31 March 2015, 科学技术文献出版社 * |
李彬之主编: "《中医灵验方》", 30 April 1991, 科学普及出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3466447A1 (en) | Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof | |
CN101569696A (en) | Chinese medicament for traumatic wound | |
CN1915351A (en) | Composition of Chinese traditional medicine in use for treating burn and scald, and product for resolving poxes, and preparation method | |
CN106581439A (en) | Traditional Chinese medicine composition for treating wounds, diabetic feet and skin ulceration, and preparation method thereof | |
CN1189197C (en) | Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration | |
CN102579709A (en) | Scar preventing and removing burn oil and preparation method thereof | |
CN113577155A (en) | Medicine for treating burn and its preparation method | |
CN101757447A (en) | Traditional Chinese medicine preparation for treating chronic gastritis | |
CN101297866B (en) | Chinese medicament oil solution for treating burn and preparation thereof | |
CN111544514A (en) | A Chinese medicinal ointment for treating burn and scald, and its preparation method | |
CN105267516A (en) | Plaster for skin surface local anesthesia | |
CN101647952A (en) | Flesh engendering and wound closing medicament for external use | |
CN101036712A (en) | Scald and burn ointment | |
CN105832817B (en) | Application of pyrroloquinoline quinine to pharmaceutical compositions for treatment of burns, scalds and traumas | |
CN1067902C (en) | Decrustation ointment for burn and its preparing process | |
CN114848778B (en) | Compound hoop ointment for diminishing inflammation, relieving pain and promoting wound healing as well as preparation method and application thereof | |
CN109331106B (en) | Red medicine preparation for wound repair and preparation method thereof | |
CN103638173B (en) | The Chinese medicine for outer use for the treatment of decubital ulcer | |
CN106692491B (en) | Ointment for removing scald and burn scars | |
CN106728328B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
CN107050298A (en) | A kind of Chinese medicine paste formulation and preparation method for treating burn and scald skin damaged | |
CN1137707C (en) | Skin rehabilitation medicine for treating burn and scald | |
CN116531460A (en) | Traditional Chinese medicine powder for treating huge bedsores and preparation method thereof | |
CN1204912C (en) | External medicine for treating burn and scald, soft tissue injury and skin disease | |
CN104689016A (en) | Externally applied traditional Chinese medicine for treating burns |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211102 |
|
RJ01 | Rejection of invention patent application after publication |